Tumor necrosis factor: A pleiotropic cytokine and therapuetic target

KJ Tracey, MD, A Cerami, Ph. D - Annual review of medicine, 1994 - annualreviews.org
KJ Tracey, MD, A Cerami, Ph. D
Annual review of medicine, 1994annualreviews.org
▪ Abstract Advances in the molecular biology of human diseases indicate that the most
striking manifestations of illness may be caused not by exogenous pathogenic or tumor
porducts, but rather by toxic peptides produced by the host itself. Tumor necrosis factor
(TNF), a polypeptide cytokine produced during infection, injury, or invasion, has proved
spivotal in triggering the lethal effects of septic shock syndrome, cachexia, and other
systemic manifestations of disease. Because removing TNF from the diseased host may …
Abstract
Advances in the molecular biology of human diseases indicate that the most striking manifestations of illness may be caused not by exogenous pathogenic or tumor porducts, but rather by toxic peptides produced by the host itself. Tumor necrosis factor (TNF), a polypeptide cytokine produced during infection, injury, or invasion, has proved spivotal in triggering the lethal effects of septic shock syndrome, cachexia, and other systemic manifestations of disease. Because removing TNF from the diseased host may prevent development of the illness, this factor has recently been the focus of intensive research. This review discusses the biology of this cytokine, with particular emphasis on its potential therapeutic role in septic shock and cachexia.
Annual Reviews